Incidence and risk factors of COVID-19 associated pneumothorax.
Muhanad TahaMorvarid ElahiKrista WahbyLobelia SamavatiPublished in: PloS one (2022)
Among 334 critically ill patients with COVID-19, the incidence of pneumothorax was 10%. Presence of pneumothorax was associated with prolonged duration of mechanical ventilation and length of hospital stay. Strikingly, receipt of tocilizumab was associated with an increased risk of developing pneumothorax.
Keyphrases